Imaging subtypes reveal distinct biological substrates and disability profiles in multiple sclerosis.
Multiple sclerosis is characterized by marked biological heterogeneity that is only partly captured by conventional clinical phenotypes and age-at-onset categories. MRI can detect focal lesions, diffuse microstructural damage and atrophy, but these measures are usually considered separately. We therefore aimed to use S...